Bortezomib (trade name Velcade) is a boronic acid that was approved by the US Food and Drug Administration in 2003 as the first drug to treat multiple myeloma, a type of white blood cell cancer. It is a proteazome blocker that is also used to treat mantle cell lymphoma. Bortezomib passed US$1 million in听sales in 2008. It has several adverse side effects, and听.
, the most authoritative and comprehensive source for chemical information.
Molecule of the Week needs your suggestions!
If your favorite molecule is not in our听archive, please send us a message. The molecule can be notable for its current or historical importance or for any quirky reason. Thank you!
Stay Ahead of the Chemistry Curve
Learn how ACS can help you stay ahead in the world of chemistry.
